Interleukin-1β-Deficient Mice

  • Giamila Fantuzzi
  • Charles A. Dinarello
Chapter
Part of the Contemporary Immunology book series (CONTIM)

Abstract

There are three members of the interleukin-1 (IL-1) gene family: IL-1α, IL-1β, and IL-1 receptor antagonist (IL-1Ra). IL-1α and IL-1β are agonists and IL-1Ra is a specific receptor antagonist. IL-1α and IL-1β are synthesized as precursor molecules, without leader sequences. The molecular weight of each precursor is 31 kDa. Processing of IL-1α or IL-1β to “mature” forms of 17 kDa requires specific cellular proteases.

Keywords

Tumor Necrosis Factor Alpha Acute Phase Protein Acute Phase Response Acute Myeloblastic Leukemia Sterile Inflammation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dinarello, C. A. (1996) Biological basis for interleukin-1 in disease. Blood 87, 2095–2147.PubMedGoogle Scholar
  2. 2.
    Colotta, F., Dower, S. K., Sims, J. E., and Mantovani, A. (1994) The type II “decoy” receptor: a novel pathway for interleukin-1. Immunol. Today 15, 562–566.PubMedCrossRefGoogle Scholar
  3. 3.
    Greenfeder, S. A., Nunes, P., Kwee, L., Labow, M., Chizzonite, R. A., and Ju, G. (1995) Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J. Biol. Chem. 270, 13,757–13, 765.Google Scholar
  4. 4.
    Lambriola-Tomkins, E., Chandran, C., Varnell, T. A., Madison, V. S., and Ju, G. (1993) Identification of residues required for binding to the human type I IL-1 receptor. Protein Eng. 6, 535–539.CrossRefGoogle Scholar
  5. 5.
    Gruetter, M. G., van Oostrum, J., Priestle, J. P., Edelmann, E., Joss, U., Feige, U., Vosbeck, K., and Schmitz, A. (1994) A mutational analysis of receptor binding sites of interleukin-13: differences in binding of human interleukin-113 muteins to human and mouse receptors. Protein Eng. 7, 663–671.CrossRefGoogle Scholar
  6. 6.
    Rubartelli, A., Cozzolino, F., Talio, M., and Sitia, R. (1990) A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. 9, 1503–1510.PubMedGoogle Scholar
  7. 7.
    Stevenson, F. T., Torrano, F., Locksley, R. M., and Lovett, D. H. (1992) Interleukin-1: the patterns of translation and intracellular distribution support alternative secretory mechanisms. J. Cell. Physiol. 152, 223–231.PubMedCrossRefGoogle Scholar
  8. 8.
    Fenton, M. J., Vermeulen, M. W., Clark, B. D., Webb, A. C., and Auron, P. E. (1988) Human pro-IL-1 beta gene expression in monocytic cells is regulated by two distinct pathways. J. Immunol. 140, 2267–2273.PubMedGoogle Scholar
  9. 9.
    Schindler, R., Ghezzi, P., and Dinarello, C. A. (1990) IL-1 induces IL-1. IV. IFN-y suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J. Immunol. 144, 2216–2220.PubMedGoogle Scholar
  10. 10.
    Auron, P. E. and Webb, A. C. (1994) Interleukin-1: a gene expression system regulated at multiple levels. Eur. Cytokine Netw. 5, 573–592.PubMedGoogle Scholar
  11. 11.
    Schindler, R., Clark, B. D., and Dinarello, C. A. (1990) Dissociation between interleukin-113 mRNA and protein synthesis in human peripheral blood mononuclear cells. J. Biol. Chem. 265, 10,232–10, 237.Google Scholar
  12. 12.
    Jobling, S. A., Auron, P. E., Gurka, G., Webb, A. C., McDonald, B., Rosenwasser, L. J., and Gehrke, L. (1988) Biological activity and receptor binding of human prointerleukin-113 and subpeptides. J. Biol. Chem. 263, 16,372–16, 378.Google Scholar
  13. 13.
    Beuscher, H. U., Gunther, C., and Rollinghoff, M. (1990) IL-143 is secreted by activated murine macrophages as biologically inactive precursor. J. Immunol. 144, 2179–2183.PubMedGoogle Scholar
  14. 14.
    Black, R. A., Kronheim, S. R., Cantrell, M., Deeley, M. C., March, C. J., Prickett, K. S., Wignall, J., Conlon, P. J., Cosman, D., Hopp, T. P., and Mochizuki, D. Y. (1988) Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J. Biol. Chem. 263, 9437–9442.PubMedGoogle Scholar
  15. 15.
    Klir, J. J., McClellan, J. L., and Kluger, M. J. (1994) Interleukin-113 causes the increase in anterior hypothalamic interleukin-6 during LPS-induced fever in rats. Am. J. Physiol. 266, R1845 — R1848.PubMedGoogle Scholar
  16. 16.
    Geiger, T., Towbin, H., Cosenti-Vargas, A., Zingel, O., Arnold, J., Rordorf, C., Glatt, M., and Vosbeck. K., (1993) Neutralization of interleukin-113 activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associate acute-phase response. Clin. Exp. Rheumatol. 11, 515–522.PubMedGoogle Scholar
  17. 17.
    van der Berg, W. B., Joosten, L. A., Helsen, M., and van de Loo, F. A. (1994) Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95, 237–243.PubMedCrossRefGoogle Scholar
  18. 18.
    Karkar, A. M., Koshino, Y., Cashman, S. J., Dash, A. C., Bonnefoy, J., Meager, A., and Rees, A. J. (1992) Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing injury in nephrotoxic nephritis in rats. Clin. Exp. Immunol. 90, 312–318.PubMedCrossRefGoogle Scholar
  19. 19.
    Perretti, M., Solito, E., and Parente, L. (1992) Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice. Agents Actions 35, 71–78.PubMedCrossRefGoogle Scholar
  20. 20.
    Flory, C. M., Jones, M. L., Miller, B. F., and Warren, J. S. (1995) Regulatory roles of tumor necrosis factor-alpha and interleukin-1 beta in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat. Am. J. Physiol. 146, 450–462.Google Scholar
  21. 21.
    Warren, J. S. (1991) Intrapulmonary interleukin 1 mediates acute immune complex alveolitis in the rat. Biochem. Biophys. Res. Commun. 175, 604–610.PubMedCrossRefGoogle Scholar
  22. 22.
    Ramilo, O., Saez-Llorens, X., Mertsola, J., Jafari, H., Olsen, K. D., Hansen, E. J., Yoshinaga, M., Ohkawara, S., Nariuchi, H., and McCracken, G. H. J. (1990) Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J. Exp. Med. 172, 497–507.PubMedCrossRefGoogle Scholar
  23. 23.
    Gibertini, M., Newton, C., Friedman, H., and Klein, T. W. (1995) IL-1 beta and TNF alpha modulate delta 9-tetrahydrocannabinol-induced catalepsy in mice. Pharmacol. Biochem. Behay. 50, 141–146.CrossRefGoogle Scholar
  24. 24.
    Opp, M. R., and Krueger, J. M. (1994) Anti-interleukin-1 beta reduces sleep and sleep rebound after sleep deprivation in rats. Am. J. Physiol. 266, R688 — R695.PubMedGoogle Scholar
  25. 25.
    Opp, M. R., and Krueger, J. M. (1994) Interleukin-1 is involved in responses to sleep deprivation in the rabbit. Brain. Res. 639, 57–65.PubMedCrossRefGoogle Scholar
  26. 26.
    Cozzolino, F., Rubartelli, A., Aldinucci, D., Sitia, R., Torcia, M., Shaw, A., and Di Guglielmo, R. (1989) Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells. Proc. Natl. Acad. Sci. USA 86, 2369–2373.PubMedCrossRefGoogle Scholar
  27. 27.
    Beauchemin, V., Villeneuve, L., Rodriguez-Cimadevilla, J. C., Rajotte, D., Kenney, J. S., Clark, S. C., and Hoang, T. (1991) Interleukin-6 production by the blast cells of acute myeloblastic leukemia: regulation by endogenous interleukin-1 and biological implications. J. Cell. Physiol. 148, 353–361.PubMedCrossRefGoogle Scholar
  28. 28.
    Rodriguez-Cimadevilla, J. C., Beauchemin, V., Villeneuve, L., Letendre, F., Shaw, A., and Hoang, T. (1990) Coordinate secretion of interleukin-1 beta and granulocyte-macrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: role of interleukin-1 as an endogenous inducer. Blood 76, 1481–1489.PubMedGoogle Scholar
  29. 29.
    Miyasaka, N., Higaki, M., Sato, K., Hashimoto, J., Taniguchi, A., Kohsaka, H., Yamamoto, K., Shichikawa, K., and Nishioka, K. (1991) Production of interleukin-1 beta-like factor with synovial cell growth promoting activity from adult T-cell leukemia cells. J. Autoimmun. 4, 223–236.PubMedCrossRefGoogle Scholar
  30. 30.
    Iwahashi, M., Tanimura, H., Yamaue, H., Tsunoda, T., Tani, M., Noguchi, K., Mizobata, S., Tamai, M., Hotta, T., and Arii, K. (1994) In vitro augmentation of cytotoxic activity of peripheral blood lymphocytes and spleen cells of cancer patients by ubenimex. Anticancer Res. 14, 1557–1562.PubMedGoogle Scholar
  31. 31.
    Yan, X. Q., Brady, G., and Iscove, N. N. (1993) Platelet-derived growth factor (PDGF) activates primitive hematopoietic precursors (pre-CFCmulti) by up-regulating IL-1 in PDGF receptor-expressing macrophages. J. Immunol. 150, 2440–2448.PubMedGoogle Scholar
  32. 32.
    Zeki, K., Nakano, Y., Inokuchi, N., Watanabe, K., Morimoto, I., Yamashita, U., and Eto, S. (1993) Autocrine stimulation of interleukin-1 in the growth of human thyroid carcinoma cell line NIM 1. J. Clin. Endocrinol. Metab. 76, 127–133.PubMedCrossRefGoogle Scholar
  33. 33.
    Molossi, S., Clausell, N., and Rabinovitch, M. (1995) Reciprocal induction of tumor necrosis factor-alpha and interleukin-1 beta activity mediates fibronectin synthesis in coronary artery smooth muscle cells. J. Cell. Physiol. 163, 19–29.PubMedCrossRefGoogle Scholar
  34. 34.
    Clausell, N. and Rabinovitch, M. (1993) Upregulation of fibronectin synthesis by interleukin-1 beta in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets. J. Clin. Invest. 92, 1850–1858.PubMedCrossRefGoogle Scholar
  35. 35.
    Rolfe, M. W., Kunkel, S. L., Standiford, T. J., Orringer, M. B., Phan, S. H., Evanoff, H. L., Burdick, M. D., and Strieter, R. M. (1992) Expression and regulation of human pulmonary fibroblast-derived monocyte chemotactic peptide-1. Am. J. Physiol. 263, L536 — L540.PubMedGoogle Scholar
  36. 36.
    Jain, B., Rubinstein, I., Robbins, R. A., and Sisson, J. H. (1995) TNF-alpha and IL-1 beta upregulate nitric oxide-dependent ciliary motility in bovine airway epithelium. Am. J. Physiol. 268, L911 — L917.PubMedGoogle Scholar
  37. 37.
    Zheng, H., Fletcher, D., Kozak, W., Jiang, M., Hofmann, K., Conn, C. A., Soszynski, D., Grabiec, C., Trumbauer, M. E., Shaw, A., Kostura, M. J., Stevens, K., Rosen, H., North, R. J., Chen, H. Y., Tocci, M. J., Kluger, M. J., and Van der Ploeg, L. H. T. (1995) Resistance to fever induction and impaired acute-phase response in interleukin-1(3 deficient mice. Immunity 3, 9–19.PubMedCrossRefGoogle Scholar
  38. 38.
    Shornick, L. P., De Togni, P., Mariathasan, S., Goellner, J., Strauss-Schoenberger, J., Karr, R. W., Ferguson, T. A., and Chaplin, D. D. (1996) Mice deficient in IL-113 manifest impaired contact hypersensitivity to trinitrochlorobenzene. J. Exp. Med. 183, 1427–1436.PubMedCrossRefGoogle Scholar
  39. 39.
    McMaster, M. T., Newton, R. C., Dey, S. K., and Andrews, G. K. (1992) Activation and distribution of inflammatory cells in the mouse uterus during the preimplantation period. J. Immunol. 148, 1699–1705.PubMedGoogle Scholar
  40. 40.
    De, M., Sanford, T. R., and Wood, G. W. (1993) Expression of interleukin 1, interleukin 6 and tumour necrosis factor a in mouse uterus during the peri-implantation period of pregnancy. J. Repr. Fert. 97, 83–89.CrossRefGoogle Scholar
  41. 41.
    Rothstein, J. L., Johnson, D., DeLoia, J. A.. Skowronski, J., Solter, D., and Knowles, B. (1992) Gene expression during preimplantation mouse development. Gene. Develop. 6, 1190–1201.Google Scholar
  42. 42.
    Granowitz, E. V., Porat, R., Mier, J. W., Pribble, J. P., Stiles, D. M., Bloedow, D. C., Catalano, M. A., Wolff, S. M., and Dinarello, C. A. (1992) Pharmacokinetics, safety, and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 4, 353–360.PubMedCrossRefGoogle Scholar
  43. 43.
    McCarthy, D. O., Kluger, M. J., and Vander, A. J. (1985) Suppression of food intake during infections: is interleukin-1 involved? Am. J. Clin. Nutr. 42, 1179–1182.PubMedGoogle Scholar
  44. 44.
    Moldawer, L. L., Anderson, C., Gelin, J., and Lundhold, K. G. (1988) Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am. J. Physiol. 254, G450 — G456.PubMedGoogle Scholar
  45. 45.
    Hellerstein, M. K., Meydani, S. N., Meydani, M., and Dinarello, C. A. (1989) Interleukin-1-induced anorexia in rat. J. Clin. Invest. 84, 228–235.PubMedCrossRefGoogle Scholar
  46. 46.
    Kozak, W., Zheng, H., Conn, C. A., Soszynski, D., Van der Ploeg, L. H. T., and Kluger, M. J. (1995) Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1ß deficient mice. Am J Physiol 269, R969 — R977.PubMedGoogle Scholar
  47. 47.
    Fantuzzi, G., Zheng, H., Faggioni, R., Benigni, F., Ghezzi, P., Sipe, J. D., Shaw, A. R., and Dinarello, C. A. (1996) Effect of endotoxin in interleukin113-deficient mice. J. Immunol., 157, 291–296.PubMedGoogle Scholar
  48. 48.
    Besedovsky, H. O., and Del Rey, A. (1996) Immune-neuro-endocrine interactions: facts and hypotheses. Endocrine Rev. 17, 64–102.Google Scholar
  49. 49.
    Gonzalez-Hernandez, J. A., Bornstein, S. R., Ehrhart-Bornstein, M., Gschwend, J. E., Gwosdow, A., Jirikowski, G., and Scherbaum, W. A. (1995) IL-1 is expressed in human adrenal gland in vivo. Possible role in local immune-adrenal axis. Clin. Exp. Immunol. 99, 137–141.PubMedCrossRefGoogle Scholar
  50. 50.
    Labeur, M. S., Arzt, E., Wiegers, G. J., Holsboer, F., and Reul, J. M. H. M. (1995) Long-term intracerebroventricular corticotropin-releasing hormone administration induces distinct changes in rat splenocyte activation and cytokine expression. Endocrinology 136, 2678–2688.PubMedCrossRefGoogle Scholar
  51. 51.
    Mengozzi, M. and Ghezzi, P. (1991) Defective tolerance to the toxic and metabolic effects of interleukin-1. Endocrinology 128, 1668–1672.PubMedCrossRefGoogle Scholar
  52. 52.
    Alexander, H. R., Doherty, G. M., Buresh, C. M., Venzon, D. J., and Norton, J. A. (1991) A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 173, 1029–1032.PubMedCrossRefGoogle Scholar
  53. 53.
    Everaerdt, B., Brouckaert, P., and Fiers, W. (1994) Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice. J. Immunol. 152, 5041–5049.PubMedGoogle Scholar
  54. 54.
    Fischer, E., Marano, M. A., Van Zee, K. J., Rock, C. S., Hawes, A. S., Thompson, W. A., DeForge, L., Kenney, J. S., Remick, D. G., Bloedow, D. C., Thompson, W. A., Lowry, S. F., and Moldawer, L. L. (1992) Interleukin1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J. Clin. Invest. 89, 1551–1557.PubMedCrossRefGoogle Scholar
  55. 55.
    Mancilla, A., Garcia, P., and Dinarello, C. A. (1993) The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats. Infect. Immunol. 61, 926–932.Google Scholar
  56. 56.
    McNamara, M. J., Norton, J. A., Nauta, R. J., and Alexander, H. R. (1993) Interleukin-1 receptor antibody (IL- lrab) protection and treatment against lethal endotoxemia in mice. J. Surg. Res. 54, 316–321.PubMedCrossRefGoogle Scholar
  57. 57.
    Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Jonhston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., Towne, E., Tracey, D., Warwell, S., Wei, F.-Y., Wong, W., Kamen, R., and Seshadri, T. (1995). Mice deficient in IL-113-converting enzyme are defective in production of mature IL-113 and resistant to endotoxic shock. Cell 80, 401–411.PubMedCrossRefGoogle Scholar
  58. 58.
    Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S.-S., and Flavell, R. A. (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-113 converting enzyme. Science 267, 2000–2003.PubMedCrossRefGoogle Scholar
  59. 59.
    Pfeffer, K., Matsuyama, T., Kundig, T. M., Wakeman, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Kronke, M., and Mak, T. W. (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457–467.PubMedCrossRefGoogle Scholar
  60. 60.
    Rothe, J., Lesslauer, W., Lotscher, H., Lang, Y., Koebel, P., Kontgen, F., Althage, A., Zinkernagel, R., Steinmetz, M., and Bluethmann, H. (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798–802.CrossRefGoogle Scholar
  61. 61.
    Car, B. D., Eng, V. M., Schnyder, B., Ozmen, L., Huang, S., Gallay, P., Heumann, D., Aguet, M., and Ryffel, B. (1994) Interferon-y receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179, 1437–1444.PubMedCrossRefGoogle Scholar
  62. 62.
    Garcia, I., Miyazaki, Y., Araki, K., Araki, M., Lucas, R., Grau, G. E., Milon, G., Belkaid, Y., Monixi, C., Lesslauer, W., and Vassalli, P. (1995) Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 25, 2401–2407.PubMedCrossRefGoogle Scholar
  63. 63.
    Goris, R. J. A., Boekholtz, W. K. F., van Bebber, I. P. T., Nuytinck, J. K. S., and Schillings, P. H. M. (1986) Multiple-organ failure and sepsis without bacteria. An experimental model. Arch. Surg. 121, 897–901.PubMedCrossRefGoogle Scholar
  64. 64.
    Fantuzzi, G., Sacco, S., Ghezzi, P., and Dinarello, C. A. (1997) Physiologic and cytokine responses in interleukin-113-deficient mice following zymosaninduced inflammation. Am. J. Physiol.,in press.Google Scholar
  65. 65.
    Von Asmuth, E. J. U., Maessen, J. G., Van der Linden, C. J., and Buurman, W. A. (1990) Tumour necrosis factor alpha (TNF-a) and interleukin 6 in a zymosan-induced shock model. Scand. J. Immunol. 32, 313–319.CrossRefGoogle Scholar
  66. 66.
    Nakane, A. (1992) TNF in lysteriosis, in Tumor Necrosis Factor: The Molecules and Their Emerging Role in Medicine ( Beutler, B. ed.), Raven, New York, pp. 285–297.Google Scholar
  67. 67.
    Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., and Kohler, G. (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339–342.PubMedCrossRefGoogle Scholar
  68. 68.
    Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., and Stewart, T. A. (1993) Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259, 1739–1742.PubMedCrossRefGoogle Scholar
  69. 69.
    Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijio, R., Vilcek, J., Zinkernagel, R. M., and Aguet, M. (1993) Immune response in mice that lack the interferon-y receptor. Science 259, 1742–1745.PubMedCrossRefGoogle Scholar
  70. 70.
    Rogers, H. W., Tripp, C. S., Schreiber, R. D., and Unanue, E. R. (1994) Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine listeriosis. J. Immunol. 153, 2093–2101.PubMedGoogle Scholar
  71. 71.
    Conn, C. A., McClellan, J. L., Maassab, H. F., Smith, C. W., Majde, J. A., and Kluger, M. J. (1995) Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. 268, R78 — R84.PubMedGoogle Scholar
  72. 72.
    Alheim, K., Chai, Z., Fantuzzi, G., Hasanvan, H., Malinovski, D., Di Santo, E., Ghezzi, P., Dinarello, C. A., and Bartfai, T. (1997) Hyper-responsive febrile reactions to IL-la and altered brain cytokine mRNA and serum cytokine levels, in IL-113 deficient mice. Proc. Natl. Acad. Sci. USA,in press.Google Scholar
  73. 73.
    Chai, Z., Gatti, S., Toniatti, C., Poli, V., and Bartfai, T. (1996) Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-113: a study on IL-6-deficient mice. J. Exp. Med. 183, 311–316.PubMedCrossRefGoogle Scholar
  74. 74.
    Leon, L. R., Conn, C. A., Glaccum, M., and Kluger, M. J. (1996) IL-1 type I receptor mediates the acute phase response to turpentine, but not lipopolysaccharide, in mice. Am. J. Physiol. 271, R1668 — R1675.PubMedGoogle Scholar
  75. 75.
    Grunfeld, C., Zhao, C., Fuller, J., Pollock, A., Moser, A., Friedman, J., and Feingold, K. R. (1996) Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. A role for leptin in the anorexia of infection. J. Clin. Invest. 97, 2152–2157.PubMedCrossRefGoogle Scholar
  76. 76.
    Gershenwald, J. E., Fong, Y., Fahey, T. J. I., Calvano, S. E., Chizzonite, R., Kilian, P. L., Lowry, S. F., and Moldawer, L. L. (1990) Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc. Nail. Acad. Sci. USA 87, 4966–4970.CrossRefGoogle Scholar
  77. 77.
    Kent, S., Kelley, K. W., and Dantzer, R. (1992) Effects of lipopolysaccharide on food-motivated behaviour in the rat are not blocked by an interleukin-1 receptor antagonist. Neurosci. Lett. 145, 83–86.PubMedCrossRefGoogle Scholar
  78. 78.
    Fantuzzi, G., and Ghezzi, P. (1993) Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases. Mediat. Inflamm. 2, 263–270.CrossRefGoogle Scholar
  79. 79.
    Van Zee, K. J., Coyle, S. M., Calvano, S. E., Oldenburg, H. S. A., Stiles, D. M., Pribble, J., Catalano, M. A., Moldawer, L. L., and Lowry, S. F. (1995) Influence of IL-1 receptor blockade on the human response to endotoxemia. J. Immunol. 154, 1499–1507.PubMedGoogle Scholar
  80. 80.
    Dunn, A. J. (1992) The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin. Brain Res. Bull. 29, 807–812.PubMedCrossRefGoogle Scholar
  81. 81.
    Rivier, C., Chizzonite, R., and Vale, W. (1989) In the mouse, the activation of the Hypothalamic—Pituitary—adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 125, 2800–2805.PubMedCrossRefGoogle Scholar
  82. 82.
    Fantuzzi, G., and Dinarello, C. A. (1996) The inflammatory response in interleukin-113-deficient mice: comparison with other cytokine-related knock-out mice. J. Leukoc. Biol. 59, 489–493.PubMedGoogle Scholar
  83. 83.
    Turnbull, A. V., Dow, R. C., White, A., Fink, G., and Rothwell, N. J. (1994) Mechanisms of activation of the pituitary—adrenal axis by tissue injury in the rat. Psychoneuroendocrinology 19, 165–178.PubMedCrossRefGoogle Scholar
  84. 84.
    Bertini, R., Bianchi, M., and Ghezzi, P. (1988) Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 167, 1708–1712.PubMedCrossRefGoogle Scholar
  85. 85.
    Lang, C. H. (1995) Role of cytokines in glucose metabolism. In Human Cytokines: Their Role in Disease and Therapy ( Aggarwal, B. B. and Puri, R., eds.), Blackwell Science, Boston, MA, pp. 271–284.Google Scholar
  86. 86.
    Baumann, H., and Gauldie, J. (1994) The acute phase response. Immunol. Today 15, 74–80.PubMedCrossRefGoogle Scholar
  87. 87.
    Steel, D. M., and Whithead, A. S. (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15, 81–88.PubMedCrossRefGoogle Scholar
  88. 88.
    Fantuzzi, G., Ku, G., Harding, M. W., Livingston, D. J., Kuida, K., Flavell, R. A., and Dinarello, C. A. (1997) Response to local inflammation of IL-113 converting enzyme-deficient mice. J. Immunol. 158, 1818–1824.PubMedGoogle Scholar
  89. 89.
    Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P., and Poli, V. (1994) Defective inflammatory response in interleukin-6 deficient mice. J. Exp. Med. 180, 1243–1250.PubMedCrossRefGoogle Scholar
  90. 90.
    Mier, J. M., Vachino, G., Van der Meer, J., Numerof, R. P., Adams, S., Cannon, J. G., Bernheim, H. A., Parkinson, D. R., and Dinarello, C. A. (1988) Induction of circulating tumor necrosis factor (TNFa) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J. Clin. Immunol. 8, 426–436.PubMedCrossRefGoogle Scholar
  91. 91.
    Economu, J. S., Hoban, M., Lee, J. D., Essner, R., Swisher, S., McBride, W., Hoon, D. B., and Morton, D. L. (1991) Production of tumor necrosis factora and interferon-y in interleukin-2-treated melanoma patients: correlation with clinical toxicity. Cancer Immunol. Immunother. 34, 49–52.CrossRefGoogle Scholar
  92. 92.
    Numerof, R. P., Sipe, J. D., Trehu, E. G., Dinarello, C. A., and Mier, J. W. (1992) Suppression of IL-2-induced SAA gene expression in mice by the administration of an IL-1 receptor antagonist. Cytokine 4, 555–560.PubMedCrossRefGoogle Scholar
  93. 93.
    Mengozzi, M., and Ghezzi, P. (1993) Cytokine down-regualtion in endotoxin tolerance. Eur. Cytokine Netw. 4, 89–98.PubMedGoogle Scholar
  94. 94.
    Henricson, B. E., Neta, R., and Vogel, S. N. (1991) An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. Infect. Immun. 59, 1188–1191.PubMedGoogle Scholar
  95. 95.
    Enk, A H, and Katz, S. I. (1991) Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA 89, 1398–1402.CrossRefGoogle Scholar
  96. 96.
    Enk, A. H., Angeloni, V. L., Udey, M. C., and Katz, S. I. (1993) An essential role for Langherans cell-derived IL-10 in the initiation of primary immune responses in skin. J. Immunol. 150, 3698–3704.PubMedGoogle Scholar
  97. 97.
    Granowitz, E. V., Porat, R., Mier, J. W., Orencole, S. F., Callahan, M. V., Cannon, J. G., Lynch, E. A., Ye, K., Poutsiaka„ D. D., Vannier, E., Shapiro, L., Pribble, J. P., Stiles, D. M., Catalano, M. A., Wolff, S. M., and Dinarello, C. A. (1993) Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans. Blood 82, 2985–2990.PubMedGoogle Scholar
  98. 98.
    Bank, U., Schneemilch, C., Reinhold, D., Kunz, D., and Ansorge, S. (1995) Kinetics of cytokine secretion in locally restricted inflammatory processes following tissue injury in vivo. Cytokine 7, 618 (Abstract).Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Giamila Fantuzzi
  • Charles A. Dinarello

There are no affiliations available

Personalised recommendations